Skip to main content

Advertisement

Log in

Relative value of the lumbar spine and hip bone mineral density and bone turnover markers in men with ankylosing spondylitis

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The purpose of this study is to evaluate bone mineral density (BMD) and bone turnover markers in men with ankylosing spondylitis (AS) and to determine their relationship with clinical features and disease activity. Serum carboxi terminal cross-linked telopeptide of type I collagen (CTX), osteocalcin (OC) levels, and BMD of lumbar spine and proximal femur were evaluated in 44 males with AS, 18–60 years of age, and compared with those of 39 age-matched healthy men. Men with AS had a significantly lower BMD at the femoral neck and total hip as compared to age-matched controls (all p < 0.01). Osteopaenia or osteoporosis was found in 59.5% AS patients at the lumbar spine and in 47.7% at the femoral neck. Mean serum levels of OC and CTX were similar in AS patients and controls. There were no significant differences in BMD and bone turnover markers when comparing subgroups stratified according to disease duration or presence of peripheral arthritis. No correlations were found between disease activity markers and BMD or OC and CTX. In a cohort of relatively young males with AS, we found a high incidence of osteopaenia and osteoporosis. Disease activity and duration did not show any significant influence on BMD or serum levels of OC and CTX.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Toussirot E, Wendling D (2000) Bone mass in ankylosing spondylitis. Clin Exp Rheumatol 18(Suppl 21):S16–S20

    Google Scholar 

  2. Wendling D (2007) Bone and matrix remodeling markers: a new tool for assessment of treatment efficacy in ankylosing spondylitis? J Rheumatol 34:1647–1649

    PubMed  CAS  Google Scholar 

  3. Marhoffer W, Schatz H, Stracke H et al (1991) Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis. J Rheumatol 18:1158–1162

    PubMed  CAS  Google Scholar 

  4. Rosen HN, Moses AC, Garber J et al (2000) Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcif Tissue Int 66:100–103

    Article  PubMed  CAS  Google Scholar 

  5. Van Der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368

    Article  PubMed  Google Scholar 

  6. Garrett S, Jenkinson T, Kennedy LG et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Disease Activity Index. J Rheumatol 21:2286–2291

    PubMed  CAS  Google Scholar 

  7. Calin A, Garret S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheumatol 21:2281–2285

    PubMed  CAS  Google Scholar 

  8. World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. WHO, Geneva

    Google Scholar 

  9. Donnelly S, Doyle DV, Denton A et al (1994) Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 53:117–121

    Article  PubMed  CAS  Google Scholar 

  10. Capaci K, Hepguler S, Argin M et al (2003) Bone mineral density in mild and advanced ankylosing spondylitis. Yonsei Med J 44:379–384

    PubMed  Google Scholar 

  11. Baek HJ, Kang SW, Lee YJ et al (2005) Osteopenia in men with mild and severe ankylosing spondylitis. Rheumatol Int 26:30–34

    Article  PubMed  CAS  Google Scholar 

  12. Geusens P, Vosse D, van der Linden S (2007) Osteoporosis and vertebral fractures in ankylosing spondylitis. Curr Opin Rheumatol 19:335–339

    Article  PubMed  Google Scholar 

  13. Bessant R, Keat A (2002) How should clinicians manage osteoporosis in ankylosing spondylitis? J Rheumatol 29:1511–1519

    PubMed  Google Scholar 

  14. Speden DJ, Calin AI, Ring FJ et al (2002) Bone mineral density, calcanean ultrasound, and bone turnover markers in women with ankylosing spondylitis. J Rheumatol 29:516–521

    PubMed  Google Scholar 

  15. Toussirot E, Michel F, Wendling D (2001) Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. J Rheumatol 40:882–888

    Article  CAS  Google Scholar 

  16. Gratacós J, Collado A, Pons F et al (1999) Significant loss of bone mass in patients with early, active ankylosing spondylitis. A follow-up study. Arthritis Rheum 42:2319–2324

    Article  PubMed  Google Scholar 

  17. Maillefert JF, Aho LS, El Maghraoui A et al (2001) Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study. Osteoporos Int 12:605–609

    Article  PubMed  CAS  Google Scholar 

  18. Bronson WD, Walker SE, Hillman LS et al (1998) Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis. J Rheumatol 25:929–935

    PubMed  CAS  Google Scholar 

  19. Toussirot E, Ricard-Blum S, Dumoulin G et al (1999) Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis. Rheumatology 38:21–27

    Article  PubMed  CAS  Google Scholar 

  20. Mitra D, Elvis DM, Collins AJ (1999) Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relantionship with bone mineral density and vertebral fractures. J Rheumatol 26:2201–2204

    PubMed  CAS  Google Scholar 

  21. Borman P, Bodur H, Bingöl N et al (2001) Bone mineral density and bone turnover markers in a group of male ankylosing spondylitis patients: relationship to disease severity. J Clin Rheumatol 7:315–321

    Article  PubMed  CAS  Google Scholar 

  22. El Maghraoui A, Borderie D, Cherruau B et al (1999) Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 26:2205–2209

    PubMed  CAS  Google Scholar 

  23. Franck H, Meurer T, Hofbauer LC (2004) Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in ankylosing spondylitis. J Rheumatol 31:2236–2241

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This article would not have been possible without the financial support of the EULAR Scholarship Committee to whom we wish to convey our deepest gratitude. The authors would also like to acknowledge the technical support provided by Livia Otoiu and “Osart” Osteoarthrology Centre of Cluj Napoca, Romania and express thanks to Fernando Rodrίguez Cantalejo for his help with the biochemical tests.

Disclosures

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Laura Muntean.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muntean, L., Rojas-Vargas, M., Font, P. et al. Relative value of the lumbar spine and hip bone mineral density and bone turnover markers in men with ankylosing spondylitis. Clin Rheumatol 30, 691–695 (2011). https://doi.org/10.1007/s10067-010-1648-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-010-1648-3

Keywords

Navigation